Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
The Lancet. Oncology|June 28, 2016
Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trialLaurie H Sehn, Neil Chua, Jiri Mayer, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 28, 2019
Profiling of biological and environmental risk factors in immunogenetic subgroups of chronic lymphocytic leukemia - Czech national studyKamila Stranska, Karla Plevova, Hana Skuhrova Francova, et al.
Blood|July 7, 2005
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMTCharles Crawley, Richard Szydlo, Marc Lalancette, et al.
Blood|May 4, 2021
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment optionsJitka Malcikova, Sarka Pavlova, Barbara Kunt Vonkova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2012
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemiaHagop M Kantarjian, Xavier G Thomas, Anna Dmoszynska, et al.
Medical Oncology (Northwood, London, England)|April 1, 2003
Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administrationRoman Hájek, Daniela Zácková, Tomás Büchler, et al.
The Lancet. Haematology|February 5, 2020
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension studyHeinz Gisslinger, Christoph Klade, Pencho Georgiev, et al.
Blood Advances|February 22, 2024
Long-term treatment with rilzabrutinib in patients with immune thrombocytopeniaDavid J Kuter, Jiri Mayer, Merlin Efraim, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 23, 2012
Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009Zdenek Racil, Barbora Weinbergerova, Iva Kocmanova, et al.
Haematologica|September 18, 2012
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapseTim Pfeiffer, Michael Schleuning, Jiri Mayer, et al.
Pageof 23